Skip to main content

pLenti6.3-D122p53
(Plasmid #259517)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 259517 Standard format: Plasmid sent in bacteria as agar stab 1 $94

Backbone

  • Vector backbone
    pLenti6.3/TO/V5-DEST
  • Backbone manufacturer
    Invitrogen (Thermo Fisher Scientific)
  • Backbone size w/o insert (bp) 7521
  • Total vector size (bp) 8374
  • Vector type
    Mammalian Expression, Lentiviral
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Delta122p53
  • Species
    M. musculus (mouse)
  • Insert Size (bp)
    853
  • Entrez Gene
    Trp53 (a.k.a. Tp53, bbl, bfy, bhy, p44, p53)
  • Tag / Fusion Protein
    • FLAG (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site SpeI (not destroyed)
  • 3′ cloning site Mlu I (not destroyed)
  • 5′ sequencing primer CMV-Forward
  • 3′ sequencing primer Internal
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry

Trademarks:

  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Please visit https://doi.org/10.64898/2025.12.31.697195 for bioRxiv preprint.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pLenti6.3-D122p53 was a gift from Curtis Harris & Izumi Horikawa (Addgene plasmid # 259517 ; http://n2t.net/addgene:259517 ; RRID:Addgene_259517)
  • For your References section:

    Senescence-inhibitory Delta133p53alpha counteracts accelerated ageing and mortality. Yamada L, Liu H, von Muhlinen N, Harris CC, Horikawa I. bioRxiv [Preprint]. 2026 Feb 7:2025.12.31.697195. doi: 10.64898/2025.12.31.697195. 10.64898/2025.12.31.697195 PubMed 41509461